Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents
US4892865A · kind A · utility
37Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 1987 |
| Grant date | Jan 9, 1990 |
| Priority date | — |
| Expiry date | Dec 1, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of certain substituted pyrrolo[2,3-d]-pyrimidine nucleosides in the treatment of viral infections, in particular those caused by human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus. These substituted compounds retain antiviral properties present in their parent compounds yet exhibit significantly decreased levels of cytotoxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.